Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Next Generation Herpes Simplex Virus Vaccines"

Vaccine

Volumn 32, Issue 14, 2014, Pages 1561-1562

  Knipe, David M ^a   Corey, Lawrence ^b   Cohen, Jeffrey I ^c   Deal, Carolyn D ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b USA   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE;

GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFECTION RISK; MORBIDITY; NOTE; PRIORITY JOURNAL; VERTICAL TRANSMISSION; WORKSHOP;

HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HUMANS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (U.S.); RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES; VACCINATION; VIRAL ENVELOPE PROTEINS;

EID: 84896701349     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.052     Document Type: Note

References (0)